Atlas Trials

Phase I-II Clinical Trial With Autologous Bone Marrow Derived Mesenchymal Stem Cells for the Therapy of Multiple Sclerosis

Clinical trial NCT02035514 · COMPLETED

Trial details

NCT number
NCT02035514
Sponsor
Germans Trias i Pujol Hospital
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Relapsing Remitting Multiple Sclerosis (RRMS)
Start date
2013-12-01
Primary completion
2016-07-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.